Sarah Cannon Expert Discusses Early Stage Breast Cancer on Fox News
Dr. Erika Hamilton, Associate Director of the Breast Cancer and Gynecologic Cancer Research Program at the Sarah Cannon Research Institute – the research arm of our global cancer enterprise, Sarah Cannon – was featured on Fox News in August to discuss a study released on DCIS, early stage breast cancer. DCIS (Ductal Carcinoma In Situ), commonly referred to as “stage zero breast cancer”, is an abnormal collection of cancer cells inside the milk ducts of the breasts. According to the American Cancer Society, approximately 60,000 women are diagnosed with DCIS each year. That’s one out of five new breast cancer cases annually.
How should DCIS be treated? Is surgery necessary or effective? Watch Dr. Hamilton’s interview to learn more about DCIS and the questions surrounding treatment options for this particular condition.
Sarah Cannon provides state-of-the-art cancer care and access to clinical trials close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
You may also like...
About HCA Healthcare
HCA Healthcare, one of the nation's leading providers of healthcare services, is comprised of 182 hospitals and more than 2,300 sites of care, in 20 states and the United Kingdom. Our more than 283,000 colleagues are connected by a single purpose — to give patients healthier tomorrows.
As an enterprise, we recognize the significant responsibility we have as a leading healthcare provider within each of the communities we serve, as well as the opportunity we have to improve the lives of the patients for whom we are entrusted to care. Through the compassion, knowledge and skill of our caregivers, and our ability to leverage our scale and innovative capabilities, HCA Healthcare is in a unique position to play a leading role in the transformation of care.